T. Rowe Price Associates
KALA icon

T. Rowe Price Associates’s KALA BIO KALA Stock Holding History

T. Rowe Price Associates’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36
Closed -$20K – 2957
2022
Q3 		$20K Buy
36
+30
+500% +$23.6K ﹤0.01% 2912
2022
Q2 		$5K Sell
6
-46
-88% -$72.2K ﹤0.01% 2948
2022
Q1 		$180K Sell
52
-18
-26% -$47.2K ﹤0.01% 2738
2021
Q4 		$211K Buy
70
+16
+30% +$74.2K ﹤0.01% 2733
2021
Q3 		$352K Buy
54
+31
+135% +$268K ﹤0.01% 2523
2021
Q2 		$301K Buy
23
+6
+35% +$94.3K ﹤0.01% 2598
2021
Q1 		$292K Buy
17
+3
+21% +$58.6K ﹤0.01% 2574
2020
Q4 		$238K Buy
14
+8
+133% +$151K ﹤0.01% 2506
2020
Q3 		$114K Sell
6
-102
-94% -$2.34M ﹤0.01% 2505
2020
Q2 		$2.83M Buy
+108
New +$3.06M ﹤0.01% 1465
2019
Q4 		– Sell
-25
Closed -$239K – 2540
2019
Q3 		$239K Sell
25
-75
-75% -$913K ﹤0.01% 2357
2019
Q2 		$1.59M Sell
100
-7
-7% -$116K ﹤0.01% 1667
2019
Q1 		$2.22M Sell
107
-12
-10% -$213K ﹤0.01% 1565
2018
Q4 		$1.46M Sell
119
-46
-28% -$797K ﹤0.01% 1660
2018
Q3 		$4.06M Buy
+165
New +$5.03M ﹤0.01% 1481

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates's KALA Position: Q4 2022 in Review

T. Rowe Price Associates sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 36 shares — an estimated $20K sold.

T. Rowe Price Associates first reported a position in KALA in Q3 2018 and held it in 15 quarters. The position peaked at $4.06M in Q3 2018. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • T. Rowe Price Associates reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 36 KALA BIO shares in Q4 2022, an estimated $20K.
  • T. Rowe Price Associates first reported a position in KALA BIO in Q3 2018 and held it in 15 quarters.
  • T. Rowe Price Associates's KALA BIO position peaked at $4.06M in Q3 2018.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.